April 2022

April 2022

We celebrate the best that the pharma industry has to offer with the 2022 Power List, the inaugural Company of the Year Awards, and the grand winner of the Innovation Awards. Also in this issue, experts share their thoughts on mRNA analysis, Industry 4.0, and flexible cleanrooms. Ukrainian company Enamine explains how drug discovery has been affected by Russia’s Ukraine invasion, and we speak with Novo Nordisk’s Ludovic Helfgott about rare diseases.

Recent Issues